Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vaccines

Free Subscription Articles published in JAMA Retrieve available abstracts of 249 articles: HTML format

Single Articles

June 2022
1. ABBASI J
   COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
   JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.
   PubMed    
   
   
   
2. LARKIN HD
   mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
   JAMA. 2022;327:2280.
   PubMed    
   
   
   
3. LARKIN HD
   Maternal RSV Vaccine Could Protect Infants, Interim Analysis Suggests.
   JAMA. 2022;327:2182.
   PubMed    
   
   
   
4. KATZ SE, Edwards K
   Protecting Children Against Omicron.
   JAMA. 2022;327:2195-2197.
   PubMed    
   
   
   
5. JONES JM, Opsomer JD, Stone M, Benoit T, et al
   Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
   JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.
   PubMed    
   
   
   
6. LI Y
   Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave.
   JAMA. 2022;327:2147-2148.
   PubMed    
   
   
   
7. TAI CG, Maragakis LL, Connolly S, DiFiori J, et al
   Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
   JAMA. 2022 Jun 2. pii: 2793169. doi: 10.1001/jama.2022.9479.
   PubMed    
   
   
   
8. RUBIN R
   Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.
   JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.
   PubMed    
   
   
   May 2022
9. WEISS SR
   Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
   JAMA. 2022;327:2019-2020.
   PubMed    
   
   
   
10. OSTER ME, Shay DK, Shimabukuro TT
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
    JAMA. 2022;327:2020-2021.
    PubMed    
    
    
    
11. KUEHN BM
    Cardiac Complications More Common After COVID-19 Than Vaccination.
    JAMA. 2022;327:1951.
    PubMed    
    
    
    
12. FLEMING-DUTRA KE, Britton A, Shang N, Derado G, et al
    Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    JAMA. 2022 May 13. pii: 2792524. doi: 10.1001/jama.2022.7493.
    PubMed     Abstract available
    
    
    
13. DORABAWILA V, Hoefer D, Bauer UE, Bassett MT, et al
    Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.
    JAMA. 2022 May 13. pii: 2792525. doi: 10.1001/jama.2022.7319.
    PubMed    
    
    
    
14. LARKIN HD
    Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3.
    JAMA. 2022;327:1748.
    PubMed    
    
    
    
15. LARKIN HD
    Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses.
    JAMA. 2022;327:1748.
    PubMed    
    
    
    
16. KUEHN BM
    Age Range Is Expanded for Universal Hepatitis B Vaccination.
    JAMA. 2022;327:1749.
    PubMed    
    
    
    
17. KUEHN BM
    mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
    JAMA. 2022;327:1749.
    PubMed    
    
    
    
18. SLOMSKI A
    Studies Examine Risk of Hearing Loss After COVID-19 Vaccination.
    JAMA. 2022;327:1641.
    PubMed    
    
    
    
19. MARKS P, Woodcock J, Califf R
    COVID-19 Vaccination-Becoming Part of the New Normal.
    JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.
    PubMed    
    
    
    April 2022
20. KUEHN BM
    COVID-19 Vaccine Effectiveness in Youth Varies by Age, Variant.
    JAMA. 2022;327:1540.
    PubMed    
    
    
    
21. RAZZAGHI H, Meghani M, Crane B, Ellington S, et al
    Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics.
    JAMA. 2022 Apr 22. pii: 2791659. doi: 10.1001/jama.2022.6834.
    PubMed    
    
    
    
22. LARKIN HD
    Fractionating COVID-19 Vaccine Doses May Save Lives.
    JAMA. 2022;327:1438.
    PubMed    
    
    
    
23. WOLFSON AR, Freeman EE, Blumenthal KG
    Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
    JAMA. 2022 Apr 14. pii: 2791317. doi: 10.1001/jama.2022.5247.
    PubMed    
    
    
    
24. ABBASI J
    Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
    JAMA. 2022;327:1323.
    PubMed    
    
    
    
25. ABBASI J
    Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations.
    JAMA. 2022;327:1323.
    PubMed    
    
    
    
26. KUEHN BM
    Myocarditis Adverse Event Less Common After COVID-19 Vaccine Booster.
    JAMA. 2022;327:1324.
    PubMed    
    
    
    
27. SLOMSKI A
    Maternal COVID-19 Vaccine Safe for Infants.
    JAMA. 2022;327:1218.
    PubMed    
    
    
    
28. NISSEN SE, Wolski K, Balog C, Swerdlow DI, et al
    Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
    JAMA. 2022 Apr 3. pii: 2790912. doi: 10.1001/jama.2022.5050.
    PubMed     Abstract available
    
    
    
29. NATTINO G, Castiglioni S, Cereda D, Della Valle PG, et al
    Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021.
    JAMA. 2022 Apr 1. pii: 2790911. doi: 10.1001/jama.2022.4908.
    PubMed    
    
    
    March 2022
30. BRUXVOORT K, Slezak J, Qian L, Sy LS, et al
    Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
    JAMA. 2022 Mar 25. pii: 2790492. doi: 10.1001/jama.2022.2540.
    PubMed     Abstract available
    
    
    
31. KHARBANDA EO, Vazquez-Benitez G
    COVID-19 mRNA Vaccines During Pregnancy: New Evidence to Help Address Vaccine Hesitancy.
    JAMA. 2022 Mar 24. pii: 2790610. doi: 10.1001/jama.2022.2459.
    PubMed    
    
    
    
32. MAGNUS MC, Ortqvist AK, Dahlqwist E, Ljung R, et al
    Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
    JAMA. 2022 Mar 24. pii: 2790608. doi: 10.1001/jama.2022.3271.
    PubMed     Abstract available
    
    
    
33. FELL DB, Dhinsa T, Alton GD, Torok E, et al
    Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
    JAMA. 2022 Mar 24. pii: 2790607. doi: 10.1001/jama.2022.4255.
    PubMed     Abstract available
    
    
    
34. SLOMSKI A
    Pneumococcal Vaccine Induces Immune Responses to 20 Serotypes.
    JAMA. 2022;327:1118.
    PubMed    
    
    
    
35. STEAD W
    One Person.
    JAMA. 2022;327:1131-1132.
    PubMed    
    
    
    
36. FRIEDENSOHN L, Levin D, Fadlon-Derai M, Gershovitz L, et al
    Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.
    JAMA. 2022 Mar 17. pii: 2790421. doi: 10.1001/jama.2022.4425.
    PubMed    
    
    
    
37. ABBASI J
    First mRNA HIV Vaccine Clinical Trial Launches.
    JAMA. 2022;327:909.
    PubMed    
    
    
    
38. KUEHN BM
    Racial and Ethnic, Gender Disparities Seen in LGBT COVID-19 Vaccination Rates.
    JAMA. 2022;327:910.
    PubMed    
    
    
    February 2022
39. ABBASI J
    Widespread Misinformation About Infertility Continues to Create COVID-19 Vaccine Hesitancy.
    JAMA. 2022 Feb 22. pii: 2789477. doi: 10.1001/jama.2022.2404.
    PubMed    
    
    
    
40. KUEHN BM
    New COVID-19 Vaccine Aims to Increase Global Vaccine Access.
    JAMA. 2022;327:614.
    PubMed    
    
    
    
41. KUEHN BM
    COVID-19 Vaccines Safe, Effective in Rheumatic Diseases.
    JAMA. 2022;327:614.
    PubMed    
    
    
    
42. BRITTON A, Fleming-Dutra KE, Shang N, Smith ZR, et al
    Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
    JAMA. 2022 Feb 14. pii: 2789294. doi: 10.1001/jama.2022.2068.
    PubMed     Abstract available
    
    
    
43. TAN SHX, Pung R, Wang LF, Lye DC, et al
    Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore.
    JAMA. 2022 Feb 11. pii: 2789151. doi: 10.1001/jama.2022.1922.
    PubMed    
    
    
    
44. ABBASI J
    Fourth COVID-19 Vaccine Dose Increases Low Antibodies.
    JAMA. 2022;327:517.
    PubMed    
    
    
    
45. KUEHN BM
    Health Care Professionals' Advice Can Increase COVID-19 Vaccination.
    JAMA. 2022;327:518.
    PubMed    
    
    
    
46. SHOOK LL, Atyeo CG, Yonker LM, Fasano A, et al
    Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection.
    JAMA. 2022 Feb 7. pii: 2788986. doi: 10.1001/jama.2022.1206.
    PubMed    
    
    
    January 2022
47. SURAN M
    Coverage of COVID-19 Vaccine Counseling for Children and Youths.
    JAMA. 2022;327:313.
    PubMed    
    
    
    
48. LI HF, Hu SM, Lv M
    Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome.
    JAMA. 2022;327:392-393.
    PubMed    
    
    
    
49. WOO EJ, Dimova RB, Mba-Jonas A
    Presumptive Guillain-Barre Syndrome Associated With Receipt of the Ad26.COV2.2.S COVID-19 Vaccine-Reply.
    JAMA. 2022;327:393-394.
    PubMed    
    
    
    
50. OSTER ME, Shay DK, Su JR, Gee J, et al
    Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
    JAMA. 2022;327:331-340.
    PubMed     Abstract available
    
    
    
51. KLOMPAS M, Karan A
    Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant.
    JAMA. 2022 Jan 24. pii: 2788503. doi: 10.1001/jama.2022.0262.
    PubMed    
    
    
    
52. ABBASI J, Rubin R, Suran M
    How the Supreme Court's COVID-19 Vaccine Mandate Rulings Could Shape the Pandemic's Next Phase.
    JAMA. 2022 Jan 21. pii: 2788486. doi: 10.1001/jama.2022.0791.
    PubMed    
    
    
    
53. OMER SB, Malani PN
    Booster Vaccination to Prevent COVID-19 in the Era of Omicron: An Effective Part of a Layered Public Health Approach.
    JAMA. 2022 Jan 21. pii: 2788487. doi: 10.1001/jama.2022.0892.
    PubMed    
    
    
    
54. GOSTIN LO, Parmet WE, Rosenbaum S
    The US Supreme Court's Rulings on Large Business and Health Care Worker Vaccine Mandates: Ramifications for the COVID-19 Response and the Future of Federal Public Health Protection.
    JAMA. 2022 Jan 21. pii: 2788481. doi: 10.1001/jama.2022.0852.
    PubMed    
    
    
    
55. ACCORSI EK, Britton A, Fleming-Dutra KE, Smith ZR, et al
    Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    JAMA. 2022 Jan 21. pii: 2788485. doi: 10.1001/jama.2022.0470.
    PubMed     Abstract available
    
    
    
56. WANG L, Davis PB, Kaelber DC, Volkow ND, et al
    Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.
    JAMA. 2022 Jan 20. pii: 2788408. doi: 10.1001/jama.2022.0210.
    PubMed    
    
    
    
57. KUEHN BM
    Vaccine Development Is Charting a New Path in Malaria Control.
    JAMA. 2022 Jan 19. pii: 2788387. doi: 10.1001/jama.2021.20627.
    PubMed    
    
    
    
58. KUEHN BM
    Vaccine Passports Help Boost Lagging Vaccination Rates.
    JAMA. 2022;327:209.
    PubMed    
    
    
    
59. ADASHI EY, Cohen IG
    The Pandemic Preparedness Program: Reimagining Public Health.
    JAMA. 2022;327:219-220.
    PubMed    
    
    
    
60. ABBASI J
    Former Biden-Harris Transition Advisors Propose a New National Strategy for COVID-19.
    JAMA. 2022 Jan 18. pii: 2788316. doi: 10.1001/jama.2022.0216.
    PubMed    
    
    
    
61. RUBIN R
    COVID-19 Vaccines Have Been Available in the US for More Than a Year-What's Been Learned and What's Next?
    JAMA. 2022 Jan 11. pii: 2788213. doi: 10.1001/jama.2022.0106.
    PubMed    
    
    
    
62. ABBASI J
    Studies Suggest COVID-19 Vaccine Boosters Save Lives.
    JAMA. 2022;327:115.
    PubMed    
    
    
    
63. ABBASI J
    Homing In On a SARS-CoV-2 Correlate of Protection.
    JAMA. 2022;327:115.
    PubMed    
    
    
    
64. ABBASI J
    COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.
    JAMA. 2022;327:115.
    PubMed    
    
    
    
65. WALD A
    Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection.
    JAMA. 2022 Jan 10. pii: 2788105. doi: 10.1001/jama.2021.23726.
    PubMed    
    
    
    
66. SPITZER A, Angel Y, Marudi O, Zeltser D, et al
    Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    JAMA. 2022 Jan 10. pii: 2788104. doi: 10.1001/jama.2021.23641.
    PubMed     Abstract available
    
    
    
67. BORIO LL, Bright RA, Emanuel EJ
    A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.
    JAMA. 2022 Jan 6. pii: 2787946. doi: 10.1001/jama.2021.24165.
    PubMed    
    
    
    December 2021
68. ABBASI J
    RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths.
    JAMA. 2021 Dec 29. pii: 2787757. doi: 10.1001/jama.2021.23772.
    PubMed    
    
    
    
69. 
    Two New Pneumococcal Vaccines-Prevnar 20 and Vaxneuvance.
    JAMA. 2021;326:2521-2522.
    PubMed    
    
    
    
70. SLOMSKI A
    More Pediatric Data for First Cell-Derived Influenza Vaccine.
    JAMA. 2021;326:2464.
    PubMed    
    
    
    
71. KUEHN BM
    Influenza Vaccination Increased During the COVID-19 Pandemic.
    JAMA. 2021;326:2465.
    PubMed    
    
    
    
72. ABBASI J
    Omicron Has Reached the US-Here's What Infectious Disease Experts Know About the Variant.
    JAMA. 2021;326:2460-2462.
    PubMed    
    
    
    
73. LAM DL, Flanagan MR
    Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer.
    JAMA. 2021 Dec 23. pii: 2787650. doi: 10.1001/jama.2021.20010.
    PubMed    
    
    
    
74. DEL RIO C, Omer SB, Malani PN
    Winter of Omicron-The Evolving COVID-19 Pandemic.
    JAMA. 2021 Dec 22. pii: 2787609. doi: 10.1001/jama.2021.24315.
    PubMed    
    
    
    
75. KUEHN BM
    Vaccination Doesn't Eliminate Delta Variant Household Transmission.
    JAMA. 2021;326:2353.
    PubMed    
    
    
    
76. COHN AC, Mahon BE, Walensky RP
    One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality.
    JAMA. 2021 Dec 21. pii: 2787504. doi: 10.1001/jama.2021.23962.
    PubMed    
    
    
    
77. LEVY M, Recher M, Hubert H, Javouhey E, et al
    Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France.
    JAMA. 2021 Dec 20. pii: 2787495. doi: 10.1001/jama.2021.23262.
    PubMed    
    
    
    
78. ADAMS LE, Waterman S, Paz-Bailey G
    Vaccination for Dengue Prevention.
    JAMA. 2021 Dec 16. pii: 2787445. doi: 10.1001/jama.2021.23466.
    PubMed    
    
    
    
79. BATES TA, McBride SK, Winders B, Schoen D, et al
    Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.
    JAMA. 2021 Dec 16. pii: 2787447. doi: 10.1001/jama.2021.22898.
    PubMed    
    
    
    
80. SURAN M
    Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19.
    JAMA. 2021 Dec 15. pii: 2787289. doi: 10.1001/jama.2021.21625.
    PubMed    
    
    
    
81. ABBASI J
    COVID-19 Vaccine Combination Was Superior in Real-world Study.
    JAMA. 2021;326:2250.
    PubMed    
    
    
    
82. WALTER K
    COVID-19 and Pregnancy.
    JAMA. 2021 Dec 10. pii: 2787240. doi: 10.1001/jama.2021.22679.
    PubMed    
    
    
    
83. 
    Current Comment.
    JAMA. 2021;326:2217.
    PubMed    
    
    
    
84. GRUNAU B, Goldfarb DM, Asamoah-Boaheng M, Golding L, et al
    Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.
    JAMA. 2021 Dec 3. pii: 2786992. doi: 10.1001/jama.2021.21921.
    PubMed    
    
    
    
85. ABBASI J
    Data Emerge From the UK's COVID-19 Vaccine Extended Dosing Interval.
    JAMA. 2021 Dec 3. pii: 2786993. doi: 10.1001/jama.2021.21963.
    PubMed    
    
    
    
86. FERNANDES B, Navin MC, Reiss DR, Omer SB, et al
    US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates.
    JAMA. 2021 Dec 2. pii: 2786984. doi: 10.1001/jama.2021.22122.
    PubMed    
    
    
    November 2021
87. RUBIN R
    COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
    JAMA. 2021 Nov 24. pii: 2786818. doi: 10.1001/jama.2021.21291.
    PubMed    
    
    
    
88. RUBIN R
    Substance Use Disorders and COVID-19 Vaccine Response.
    JAMA. 2021;326:2000.
    PubMed    
    
    
    
89. KUEHN BM
    COVID-19 Vaccine Highly Effective Against Adolescent Hospitalizations.
    JAMA. 2021;326:2002.
    PubMed    
    
    
    
90. KUEHN BM
    Unhygienic Practices Lead to Routine Vaccination-Linked Infections.
    JAMA. 2021;326:2002.
    PubMed    
    
    
    
91. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
    Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
    JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
    PubMed    
    
    
    
92. SFEIR MM, Snayd M
    Serologic Testing for Hepatitis B.
    JAMA. 2021 Nov 19. pii: 2786654. doi: 10.1001/jama.2021.19803.
    PubMed    
    
    
    
93. CHOR J, Davis AM, Rusiecki JM
    Cervical Cancer Screening Guideline for Individuals at Average Risk.
    JAMA. 2021 Nov 12. pii: 2786400. doi: 10.1001/jama.2021.13448.
    PubMed    
    
    
    
94. ABBASI J
    Flu Vaccine Candidate Elicits Enhanced Immune Response.
    JAMA. 2021;326:1784.
    PubMed    
    
    
    
95. ABBASI J
    Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
    JAMA. 2021;326:1784.
    PubMed    
    
    
    
96. ABBASI J
    "Polymutant" Spike Points Way Toward More Durable COVID-19 Vaccine.
    JAMA. 2021;326:1784.
    PubMed    
    
    
    
97. 
    Routine Smallpox Vaccination.
    JAMA. 2021;326:1876.
    PubMed    
    
    
    
98. ELIAKIM-RAZ N, Leibovici-Weisman Y, Stemmer A, Ness A, et al
    Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged >/=60 Years.
    JAMA. 2021 Nov 5. pii: 2786096. doi: 10.1001/jama.2021.19885.
    PubMed    
    
    
    
99. MOSS WJ, Gostin LO, Nuzzo JB
    Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know.
    JAMA. 2021 Nov 5. pii: 2786095. doi: 10.1001/jama.2021.20734.
    PubMed    
    
    
    
100. KLOMPAS M
     Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination.
     JAMA. 2021 Nov 4. pii: 2786040. doi: 10.1001/jama.2021.19063.
     PubMed    
     
     
     
101. TENFORDE MW, Self WH, Adams K, Gaglani M, et al
     Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
     JAMA. 2021 Nov 4. pii: 2786039. doi: 10.1001/jama.2021.19499.
     PubMed     Abstract available
     
     
     
102. CROWE EH
     The Taste of Hope.
     JAMA. 2021;326:1683-1684.
     PubMed    
     
     
     
103. ZHONG D, Xiao S, Debes AK, Egbert ER, et al
     Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.
     JAMA. 2021 Nov 1. pii: 2785919. doi: 10.1001/jama.2021.19996.
     PubMed    
     
     
     
104. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
     Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
     JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
     PubMed     Abstract available
     
     
     October 2021
105. ABBASI J
     The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
     JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.
     PubMed    
     
     
     
106. RUBIN R
     Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
     JAMA. 2021 Oct 14. pii: 2785303. doi: 10.1001/jama.2021.18143.
     PubMed    
     
     
     
107. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
     Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
     JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.
     PubMed    
     
     
     
108. ABBASI J
     India's New COVID-19 DNA Vaccine for Adolescents and Adults Is a First.
     JAMA. 2021;326:1365.
     PubMed    
     
     
     
109. ABBASI J
     Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
     JAMA. 2021;326:1365.
     PubMed    
     
     
     
110. ABBASI J
     Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
     JAMA. 2021;326:1365.
     PubMed    
     
     
     
111. KUEHN BM
     HPV Vaccination Coverage Has Increased Among Adolescents.
     JAMA. 2021;326:1366.
     PubMed    
     
     
     
112. WOO EJ, Mba-Jonas A, Dimova RB, Alimchandani M, et al
     Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021.
     JAMA. 2021 Oct 7. pii: 2785009. doi: 10.1001/jama.2021.16496.
     PubMed     Abstract available
     
     
     September 2021
113. RUBIN R
     COVID-19 Vaccine Nasal Spray.
     JAMA. 2021;326:1138.
     PubMed    
     
     
     
114. KRONMAL SL
     Shots in Arms.
     JAMA. 2021;326:1151-1152.
     PubMed    
     
     
     
115. ABBASI J
     SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
     JAMA. 2021;326:901.
     PubMed    
     
     
     
116. KUEHN BM
     Adolescent Myocarditis After COVID-19 Vaccination Is Rare.
     JAMA. 2021;326:902.
     PubMed    
     
     
     
117. KHARBANDA EO, Haapala J, DeSilva M, Vazquez-Benitez G, et al
     Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy.
     JAMA. 2021 Sep 8. pii: 2784193. doi: 10.1001/jama.2021.15494.
     PubMed    
     
     
     
118. SLOMSKI A
     Most Fully Vaccinated Patients With Cancer Have SARS-CoV-2 Antibodies.
     JAMA. 2021;326:800.
     PubMed    
     
     
     
119. BLUMENTHAL KG, Phadke NA, Bates DW
     Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink.
     JAMA. 2021 Sep 3. pii: 2784017. doi: 10.1001/jama.2021.14808.
     PubMed    
     
     
     
120. KLEIN NP, Lewis N, Goddard K, Fireman B, et al
     Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
     JAMA. 2021 Sep 3. pii: 2784015. doi: 10.1001/jama.2021.15072.
     PubMed     Abstract available
     
     
     
121. JONES JM, Stone M, Sulaeman H, Fink RV, et al
     Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
     JAMA. 2021 Sep 2. pii: 2784013. doi: 10.1001/jama.2021.15161.
     PubMed     Abstract available
     
     
     August 2021
122. STEENSELS D, Pierlet N, Penders J, Mesotten D, et al
     Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
     JAMA. 2021 Aug 30. pii: 2783797. doi: 10.1001/jama.2021.15125.
     PubMed    
     
     
     
123. RUBIN R
     Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
     JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.
     PubMed    
     
     
     
124. DETSKY AS, Bogoch II
     COVID-19 in Canada: Experience and Response to Waves 2 and 3.
     JAMA. 2021 Aug 23. pii: 2783610. doi: 10.1001/jama.2021.14797.
     PubMed    
     
     
     
125. DEL RIO C, Malani PN, Omer SB
     Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
     JAMA. 2021 Aug 18. pii: 2783478. doi: 10.1001/jama.2021.14811.
     PubMed    
     
     
     
126. EVANS A, Webster J, Flores G
     Partnering With the Faith-Based Community to Address Disparities in COVID-19 Vaccination Rates and Outcomes Among US Black and Latino Populations.
     JAMA. 2021;326:609-610.
     PubMed    
     
     
     
127. SCHAEFER GO, Leland RJ, Emanuel EJ
     Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations.
     JAMA. 2021 Aug 12. pii: 2783234. doi: 10.1001/jama.2021.13226.
     PubMed    
     
     
     
128. ABBASI J
     Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2.
     JAMA. 2021;326:473.
     PubMed    
     
     
     
129. ABBASI J
     COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity.
     JAMA. 2021;326:473.
     PubMed    
     
     
     
130. DIAZ GA, Parsons GT, Gering SK, Meier AR, et al
     Myocarditis and Pericarditis After Vaccination for COVID-19.
     JAMA. 2021 Aug 4. pii: 2782900. doi: 10.1001/jama.2021.13443.
     PubMed    
     
     
     July 2021
131. ABBASI J
     Uberantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.
     JAMA. 2021 Jul 28. pii: 2782673. doi: 10.1001/jama.2021.12915.
     PubMed    
     
     
     
132. RUBIN R
     Higher Medicare Payments for In-home COVID-19 Vaccinations.
     JAMA. 2021;326:298.
     PubMed    
     
     
     
133. KUEHN BM
     Resurgence of Pertussis Linked With Switch to Acellular Vaccine.
     JAMA. 2021;326:300.
     PubMed    
     
     
     
134. BENOTMANE I, Gautier G, Perrin P, Olagne J, et al
     Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses.
     JAMA. 2021 Jul 23. pii: 2782538. doi: 10.1001/jama.2021.12339.
     PubMed    
     
     
     
135. BATES TA, Leier HC, Lyski ZL, Goodman JR, et al
     Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples.
     JAMA. 2021 Jul 21. pii: 2782428. doi: 10.1001/jama.2021.11656.
     PubMed    
     
     
     
136. ABBASI J
     Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
     JAMA. 2021 Jul 14. pii: 2782139. doi: 10.1001/jama.2021.11717.
     PubMed    
     
     
     
137. GOLDSHTEIN I, Nevo D, Steinberg DM, Rotem RS, et al
     Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
     JAMA. 2021 Jul 12. pii: 2782047. doi: 10.1001/jama.2021.11035.
     PubMed     Abstract available
     
     
     
138. NUTI SV, Armstrong K
     Lay Epidemiology and Vaccine Acceptance.
     JAMA. 2021 Jul 7. pii: 2781943. doi: 10.1001/jama.2021.11130.
     PubMed    
     
     
     
139. WALKEY AJ, Law A, Bosch NA
     Lottery-Based Incentive in Ohio and COVID-19 Vaccination Rates.
     JAMA. 2021 Jul 2. pii: 2781792. doi: 10.1001/jama.2021.11048.
     PubMed    
     
     
     
140. SANCHEZ VAN KAMMEN M, Heldner MR, Brodard J, Scutelnic A, et al
     Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.
     JAMA. 2021 Jul 2. pii: 2781791. doi: 10.1001/jama.2021.9889.
     PubMed     Abstract available
     
     
     
141. KAVANAGH MM, Gostin LO, Sunder M
     Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic.
     JAMA. 2021 Jul 1. pii: 2781756. doi: 10.1001/jama.2021.10823.
     PubMed    
     
     
     
142. PERSAD G, Emanuel EJ
     Ethical Considerations of Offering Benefits to COVID-19 Vaccine Recipients.
     JAMA. 2021 Jul 1. pii: 2781755. doi: 10.1001/jama.2021.11045.
     PubMed    
     
     
     June 2021
143. RUBIN R
     The Search for a Single Vaccine Against Coronaviruses Yet to Come.
     JAMA. 2021 Jun 23. pii: 2781521. doi: 10.1001/jama.2021.9477.
     PubMed    
     
     
     
144. RUBIN R
     Vaccination in Residential Facilities.
     JAMA. 2021;325:2426.
     PubMed    
     
     
     
145. GONZALEZ DC, Nassau DE, Khodamoradi K, Ibrahim E, et al
     Sperm Parameters Before and After COVID-19 mRNA Vaccination.
     JAMA. 2021 Jun 17. pii: 2781360. doi: 10.1001/jama.2021.9976.
     PubMed    
     
     
     
146. BERTOLLINI R, Chemaitelly H, Yassine HM, Al-Thani MH, et al
     Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar.
     JAMA. 2021 Jun 9. pii: 2781112. doi: 10.1001/jama.2021.9970.
     PubMed    
     
     
     
147. AZZIZ-BAUMGARTNER E, Grohskopf L, Patel M
     Realizing the Potential of Maternal Influenza Vaccination.
     JAMA. 2021;325:2257-2259.
     PubMed    
     
     
     
148. MEHRABADI A, Dodds L, MacDonald NE, Top KA, et al
     Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.
     JAMA. 2021;325:2285-2293.
     PubMed     Abstract available
     
     
     
149. TALBOT TR
     COVID-19 Vaccination of Health Care Personnel as a Condition of Employment: A Logical Addition to Institutional Safety Programs.
     JAMA. 2021 Jun 7. pii: 2781011. doi: 10.1001/jama.2021.8901.
     PubMed    
     
     
     
150. GOSTIN LO, Shaw J, Salmon DA
     Mandatory SARS-CoV-2 Vaccinations in K-12 Schools, Colleges/Universities, and Businesses.
     JAMA. 2021 Jun 7. pii: 2781010. doi: 10.1001/jama.2021.9342.
     PubMed    
     
     
     
151. RYAN L
     Vaccinated but Not Protected-Living Immunocompromised During the Pandemic.
     JAMA. 2021 Jun 7. pii: 2781012. doi: 10.1001/jama.2021.9321.
     PubMed    
     
     
     
152. WOOD S, Schulman K
     When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest.
     JAMA. 2021 Jun 2. pii: 2780792. doi: 10.1001/jama.2021.7707.
     PubMed    
     
     
     May 2021
153. HOTEZ PJ, Narayan KMV
     Restoring Vaccine Diplomacy.
     JAMA. 2021 May 28. pii: 2780640. doi: 10.1001/jama.2021.7439.
     PubMed    
     
     
     
154. AL KAABI N, Zhang Y, Xia S, Yang Y, et al
     Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
     JAMA. 2021 May 26. pii: 2780562. doi: 10.1001/jama.2021.8565.
     PubMed     Abstract available
     
     
     
155. RUBIN R
     Allergic Reactions to mRNA Vaccines.
     JAMA. 2021;325:2038.
     PubMed    
     
     
     
156. DALY M, Jones A, Robinson E
     Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021.
     JAMA. 2021 May 24. pii: 2780519. doi: 10.1001/jama.2021.8246.
     PubMed    
     
     
     
157. UYEKI TM, Wentworth DE, Jernigan DB
     Influenza Activity in the US During the 2020-2021 Season.
     JAMA. 2021 May 24. pii: 2780518. doi: 10.1001/jama.2021.6125.
     PubMed    
     
     
     
158. COLLIER AY, McMahan K, Yu J, Tostanoski LH, et al
     Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.
     JAMA. 2021 May 13. pii: 2780202. doi: 10.1001/jama.2021.7563.
     PubMed     Abstract available
     
     
     
159. ABBASI J
     Personalized Cancer Vaccine Approach Safe in Early Trial.
     JAMA. 2021;325:1825.
     PubMed    
     
     
     
160. KUEHN BM
     Even Partial COVID-19 Vaccination Protects Nursing Home Residents.
     JAMA. 2021;325:1826.
     PubMed    
     
     
     
161. KUEHN BM
     Vaccine Dramatically Reduces HPV Infection Among Young Women.
     JAMA. 2021;325:1826.
     PubMed    
     
     
     
162. TANG L, Hijano DR, Gaur AH, Geiger TL, et al
     Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
     JAMA. 2021 May 6. pii: 2779854. doi: 10.1001/jama.2021.6564.
     PubMed    
     
     
     
163. ANGEL Y, Spitzer A, Henig O, Saiag E, et al
     Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
     JAMA. 2021 May 6. pii: 2779853. doi: 10.1001/jama.2021.7152.
     PubMed     Abstract available
     
     
     
164. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
     Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
     JAMA. 2021 May 5. pii: 2779852. doi: 10.1001/jama.2021.7489.
     PubMed    
     
     
     April 2021
165. SEE I, Su JR, Lale A, Woo EJ, et al
     US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
     JAMA. 2021 Apr 30. pii: 2779731. doi: 10.1001/jama.2021.7517.
     PubMed     Abstract available
     
     
     
166. KARRON RA, Key NS, Sharfstein JM
     Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine.
     JAMA. 2021 Apr 30. pii: 2779732. doi: 10.1001/jama.2021.7637.
     PubMed    
     
     
     
167. RUBIN R
     Vaccination Priorities Delay Shots for Higher-Risk People of Color.
     JAMA. 2021;325:1601.
     PubMed    
     
     
     
168. RUBIN R
     Medicare Raises Payment for Administering COVID-19 Vaccines.
     JAMA. 2021;325:1601.
     PubMed    
     
     
     
169. CHEN MM, Mott N, Clark SJ, Harper DM, et al
     HPV Vaccination Among Young Adults in the US.
     JAMA. 2021;325:1673-1674.
     PubMed    
     
     
     
170. KUEHN BM
     Israel's Real-life Evidence That Vaccine Can Prevent Severe COVID-19.
     JAMA. 2021;325:1603.
     PubMed    
     
     
     
171. BLAIN H, Tuaillon E, Gamon L, Pisoni A, et al
     Spike Antibody Levels of Nursing Home Residents With or Without Prior COVID-19 3 Weeks After a Single BNT162b2 Vaccine Dose.
     JAMA. 2021 Apr 15. pii: 2778926. doi: 10.1001/jama.2021.6042.
     PubMed    
     
     
     
172. 
     Experts Discuss COVID-19-Variants and Vaccine Efficacy, Immunosuppressed Patients, and More.
     JAMA. 2021 Apr 14. pii: 2778876. doi: 10.1001/jama.2021.5938.
     PubMed    
     
     
     
173. ABBASI J
     Data Leak Exposes Early COVID-19 Vaccine Manufacturing Hiccups.
     JAMA. 2021;325:1385.
     PubMed    
     
     
     
174. PERL SH, Uzan-Yulzari A, Klainer H, Asiskovich L, et al
     SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women.
     JAMA. 2021 Apr 12. pii: 2778766. doi: 10.1001/jama.2021.5782.
     PubMed    
     
     
     
175. GOSTIN LO, Cohen IG, Shaw J
     Digital Health Passes in the Age of COVID-19: Are "Vaccine Passports" Lawful and Ethical?
     JAMA. 2021 Apr 7. pii: 2778526. doi: 10.1001/jama.2021.5283.
     PubMed    
     
     
     
176. CHAPIN-BARDALES J, Gee J, Myers T
     Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.
     JAMA. 2021 Apr 5. pii: 2778441. doi: 10.1001/jama.2021.5374.
     PubMed    
     
     
     March 2021
177. RUBIN R
     HHS Expands Number of People Who Can Vaccinate Against COVID-19.
     JAMA. 2021;325:1134.
     PubMed    
     
     
     
178. GOSTIN LO
     The Coronavirus Pandemic 1 Year On-What Went Wrong?
     JAMA. 2021;325:1132-1133.
     PubMed    
     
     
     
179. EDARA VV, Hudson WH, Xie X, Ahmed R, et al
     Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.
     JAMA. 2021 Mar 19. pii: 2777898. doi: 10.1001/jama.2021.4388.
     PubMed    
     
     
     
180. 
     Experts Discuss COVID-19-Vaccine Questions, School Openings, and More.
     JAMA. 2021 Mar 17. pii: 2777786. doi: 10.1001/jama.2021.4121.
     PubMed    
     
     
     
181. RUBIN R
     COVID-19 Vaccines vs Variants-Determining How Much Immunity Is Enough.
     JAMA. 2021 Mar 17. pii: 2777785. doi: 10.1001/jama.2021.3370.
     PubMed    
     
     
     
182. WILENSKY GR
     2020 Revealed How Poorly the US Was Prepared for COVID-19-and Future Pandemics.
     JAMA. 2021;325:1029-1030.
     PubMed    
     
     
     
183. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
     Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
     JAMA. 2021 Mar 15. pii: 2777685. doi: 10.1001/jama.2021.4385.
     PubMed    
     
     
     
184. WILF-MIRON R, Myers V, Saban M
     Incentivizing Vaccination Uptake: The "Green Pass" Proposal in Israel.
     JAMA. 2021 Mar 15. pii: 2777686. doi: 10.1001/jama.2021.4300.
     PubMed    
     
     
     
185. STEPHENSON KE, Le Gars M, Sadoff J, de Groot AM, et al
     Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
     JAMA. 2021 Mar 11. pii: 2777598. doi: 10.1001/jama.2021.3645.
     PubMed     Abstract available
     
     
     
186. CHRISTIE A, Mbaeyi SA, Walensky RP
     CDC Interim Recommendations for Fully Vaccinated People: An Important First Step.
     JAMA. 2021 Mar 10. pii: 2777536. doi: 10.1001/jama.2021.4367.
     PubMed    
     
     
     
187. BLUMENTHAL KG, Robinson LB, Camargo CA Jr, Shenoy ES, et al
     Acute Allergic Reactions to mRNA COVID-19 Vaccines.
     JAMA. 2021 Mar 8. pii: 2777417. doi: 10.1001/jama.2021.3976.
     PubMed    
     
     
     
188. MOORE JP
     Approaches for Optimal Use of Different COVID-19 Vaccines: Issues of Viral Variants and Vaccine Efficacy.
     JAMA. 2021 Mar 4. pii: 2777390. doi: 10.1001/jama.2021.3465.
     PubMed    
     
     
     
189. DEL RIO C, Malani P
     COVID-19 in 2021-Continuing Uncertainty.
     JAMA. 2021 Mar 4. pii: 2777391. doi: 10.1001/jama.2021.3760.
     PubMed    
     
     
     
190. MURRAY CJL, Piot P
     The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
     JAMA. 2021 Mar 3. pii: 2777343. doi: 10.1001/jama.2021.2828.
     PubMed    
     
     
     
191. SAADAT S, Tehrani ZR, Logue J, Newman M, et al
     Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
     JAMA. 2021 Mar 1. pii: 2777171. doi: 10.1001/jama.2021.3341.
     PubMed    
     
     
     
192. LIVINGSTON EH, Malani PN, Creech CB
     The Johnson & Johnson Vaccine for COVID-19.
     JAMA. 2021 Mar 1. pii: 2777172. doi: 10.1001/jama.2021.2927.
     PubMed    
     
     
     February 2021
193. CREECH CB, Walker SC, Samuels RJ
     SARS-CoV-2 Vaccines.
     JAMA. 2021 Feb 26. pii: 2777059. doi: 10.1001/jama.2021.3199.
     PubMed    
     
     
     
194. GHARPURE R, Patel A, Link-Gelles R
     First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.
     JAMA. 2021 Feb 24. pii: 2777023. doi: 10.1001/jama.2021.2352.
     PubMed    
     
     
     
195. RUBIN R
     Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.
     JAMA. 2021 Feb 24. pii: 2777024. doi: 10.1001/jama.2021.2264.
     PubMed    
     
     
     
196. RUBIN R
     The Price of Success-How to Evaluate COVID-19 Vaccines When They're Available Outside of Clinical Trials.
     JAMA. 2021 Feb 18. pii: 2776787. doi: 10.1001/jama.2021.0641.
     PubMed    
     
     
     
197. WALENSKY RP, Walke HT, Fauci AS
     SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.
     JAMA. 2021 Feb 17. pii: 2776739. doi: 10.1001/jama.2021.2294.
     PubMed    
     
     
     
198. KUEHN BM
     High-Income Countries Have Secured the Bulk of COVID-19 Vaccines.
     JAMA. 2021;325:612.
     PubMed    
     
     
     
199. SHARFSTEIN JM, Goodman JL, Borio L
     The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
     JAMA. 2021 Feb 15. pii: 2776658. doi: 10.1001/jama.2021.1961.
     PubMed    
     
     
     
200. SHIMABUKURO TT, Cole M, Su JR
     Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.
     JAMA. 2021 Feb 12. pii: 2776557. doi: 10.1001/jama.2021.1967.
     PubMed    
     
     
     
201. 
     Experts Discuss COVID-19-Vaccine Doses, Virus Variants, and More.
     JAMA. 2021 Feb 10. pii: 2776539. doi: 10.1001/jama.2021.1101.
     PubMed    
     
     
     
202. BIANCHI DW, Kaeser L, Cernich AN
     Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.
     JAMA. 2021 Feb 10. pii: 2776540. doi: 10.1001/jama.2021.1865.
     PubMed    
     
     
     
203. ADHIKARI EH, Spong CY
     COVID-19 Vaccination in Pregnant and Lactating Women.
     JAMA. 2021 Feb 8. pii: 2776449. doi: 10.1001/jama.2021.1658.
     PubMed    
     
     
     
204. RASMUSSEN SA, Jamieson DJ
     Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021.
     JAMA. 2021 Feb 8. pii: 2776447. doi: 10.1001/jama.2021.1683.
     PubMed    
     
     
     
205. MEISSNER HC
     A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events.
     JAMA. 2021 Feb 5. pii: 2776308. doi: 10.1001/jama.2020.26792.
     PubMed    
     
     
     
206. LIVINGSTON EH
     Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.
     JAMA. 2021 Feb 3. pii: 2776229. doi: 10.1001/jama.2021.1375.
     PubMed    
     
     
     January 2021
207. JEAN-JACQUES M, Bauchner H
     Vaccine Distribution-Equity Left Behind?
     JAMA. 2021 Jan 29. pii: 2776053. doi: 10.1001/jama.2021.1205.
     PubMed    
     
     
     
208. MOORE JP, Offit PA
     SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.
     JAMA. 2021 Jan 28. pii: 2776039. doi: 10.1001/jama.2021.1114.
     PubMed    
     
     
     
209. LONGHURST CA, Kremer B, Maysent PS
     Rapid Implementation of a Vaccination Superstation.
     JAMA. 2021 Jan 28. pii: 2776038. doi: 10.1001/jama.2021.0801.
     PubMed    
     
     
     
210. SHIMABUKURO T, Nair N
     Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.
     JAMA. 2021 Jan 21. pii: 2775646. doi: 10.1001/jama.2021.0600.
     PubMed    
     
     
     
211. KUEHN BM
     Drop in Vaccination Causes Surge in Global Measles Cases, Deaths.
     JAMA. 2021;325:213.
     PubMed    
     
     
     
212. ABBASI J
     Broad, Durable Antibody Response in Universal Flu Vaccine Trial.
     JAMA. 2021;325:121.
     PubMed    
     
     
     
213. LARGENT EA, Miller FG
     Problems With Paying People to Be Vaccinated Against COVID-19.
     JAMA. 2021 Jan 6. pii: 2775005. doi: 10.1001/jama.2020.27121.
     PubMed    
     
     
     
214. LAURING AS, Hodcroft EB
     Genetic Variants of SARS-CoV-2-What Do They Mean?
     JAMA. 2021 Jan 6. pii: 2775006. doi: 10.1001/jama.2020.27124.
     PubMed    
     
     
     
215. GOSTIN LO
     A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.
     JAMA. 2021;325:17-18.
     PubMed    
     
     
     December 2020
216. GOSTIN LO, Salmon DA, Larson HJ
     Mandating COVID-19 Vaccines.
     JAMA. 2020 Dec 29. pii: 2774712. doi: 10.1001/jama.2020.26553.
     PubMed    
     
     
     
217. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
     National Trends in the US Public's Likelihood of Getting a COVID-19 Vaccine-April 1 to December 8, 2020.
     JAMA. 2020 Dec 29. pii: 2774711. doi: 10.1001/jama.2020.26419.
     PubMed    
     
     
     
218. RUBIN R
     Pharmacies Partner With HHS to Provide COVID-19 Vaccines.
     JAMA. 2020;324:2475.
     PubMed    
     
     
     
219. KUEHN BM
     Global Regulators Set Standards for Safe Vaccines.
     JAMA. 2020;324:2356.
     PubMed    
     
     
     
220. 
     Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More.
     JAMA. 2020;324:2354-2355.
     PubMed    
     
     
     
221. KRIST AH, Davidson KW, Mangione CM, Barry MJ, et al
     Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
     JAMA. 2020;324:2415-2422.
     PubMed     Abstract available
     
     
     
222. JIN J
     Screening for Hepatitis B in Nonpregnant Adolescents and Adults.
     JAMA. 2020;324:2452.
     PubMed    
     
     
     
223. RID A, Lipsitch M, Miller FG
     The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
     JAMA. 2020 Dec 14. pii: 2774382. doi: 10.1001/jama.2020.25053.
     PubMed    
     
     
     
224. VOLPP KG, Loewenstein G, Buttenheim AM
     Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program.
     JAMA. 2020 Dec 14. pii: 2774381. doi: 10.1001/jama.2020.24036.
     PubMed    
     
     
     
225. JOFFE S
     Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
     JAMA. 2020 Dec 14. pii: 2774383. doi: 10.1001/jama.2020.25127.
     PubMed    
     
     
     
226. PATEL MM, Uyeki TM
     Influenza Vaccine for Patients With High-risk Cardiovascular Disease.
     JAMA. 2020 Dec 4. pii: 2773988. doi: 10.1001/jama.2020.23948.
     PubMed    
     
     
     
227. VARDENY O, Kim K, Udell JA, Joseph J, et al
     Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
     JAMA. 2020 Dec 4. pii: 2773989. doi: 10.1001/jama.2020.23649.
     PubMed     Abstract available
     
     
     
228. RODRIGUES FMP, Marlow R, Simoes MJ, Danon L, et al
     Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal.
     JAMA. 2020;324:2187-2194.
     PubMed     Abstract available
     
     
     November 2020
229. DESAI AN, Majumder MS
     What Is Herd Immunity?
     JAMA. 2020;324:2113.
     PubMed    
     
     
     
230. LURIE N, Experton B
     How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign.
     JAMA. 2020 Nov 19. pii: 2773348. doi: 10.1001/jama.2020.22720.
     PubMed    
     
     
     
231. LENIS AT, Lec PM, Chamie K, Mshs MD, et al
     Bladder Cancer: A Review.
     JAMA. 2020;324:1980-1991.
     PubMed     Abstract available
     
     
     
232. SLOMSKI A
     New Guideline Calls for Cervical Cancer Screening to Begin at Age 25 Years.
     JAMA. 2020 Nov 6. pii: 2772859. doi: 10.1001/jama.2020.21706.
     PubMed    
     
     
     
233. UYEKI TM
     High-risk Groups for Influenza Complications.
     JAMA. 2020 Nov 2. pii: 2772692. doi: 10.1001/jama.2020.21869.
     PubMed    
     
     
     
234. UYEKI TM, Santoli J, Jernigan DB
     Preparing for the 2020-2021 Influenza Season.
     JAMA. 2020 Nov 2. pii: 2772691. doi: 10.1001/jama.2020.21849.
     PubMed    
     
     
     October 2020
235. JAKLEVIC MC
     Nursing Homes' Next Test-Vaccinating Workers Against COVID-19.
     JAMA. 2020 Oct 28. pii: 2772581. doi: 10.1001/jama.2020.21354.
     PubMed    
     
     
     
236. BELL BP, Romero JR, Lee GM
     Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation.
     JAMA. 2020 Oct 22. pii: 2772326. doi: 10.1001/jama.2020.20847.
     PubMed    
     
     
     
237. LEE GM, Romero JR, Bell BP
     Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
     JAMA. 2020 Oct 16. pii: 2772137. doi: 10.1001/jama.2020.19692.
     PubMed    
     
     
     
238. GOODMAN JL, Grabenstein JD, Braun MM
     Answering Key Questions About COVID-19 Vaccines.
     JAMA. 2020 Oct 16. pii: 2772138. doi: 10.1001/jama.2020.20590.
     PubMed    
     
     
     
239. PATEL MM, Jackson ML, Ferdinands J
     Postlicensure Evaluation of COVID-19 Vaccines.
     JAMA. 2020 Oct 16. pii: 2772136. doi: 10.1001/jama.2020.19328.
     PubMed    
     
     
     
240. SCHMIDT H, Gostin LO, Williams MA
     Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
     JAMA. 2020 Oct 14. pii: 2771874. doi: 10.1001/jama.2020.20571.
     PubMed    
     
     
     
241. 
     Influenza Vaccine for 2020-2021.
     JAMA. 2020 Oct 2. pii: 2771510. doi: 10.1001/jama.2020.19507.
     PubMed    
     
     
     September 2020
242. STEPHENS DS, McElrath MJ
     COVID-19 and the Path to Immunity.
     JAMA. 2020 Sep 11. pii: 2770758. doi: 10.1001/jama.2020.16656.
     PubMed    
     
     
     August 2020
243. SOLOMON DA, Sherman AC, Kanjilal S
     Influenza in the COVID-19 Era.
     JAMA. 2020 Aug 14. pii: 2769676. doi: 10.1001/jama.2020.14661.
     PubMed    
     
     
     July 2020
244. WIERSINGA WJ, Rhodes A, Cheng AC, Peacock SJ, et al
     Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
     JAMA. 2020 Jul 10. pii: 2768391. doi: 10.1001/jama.2020.12839.
     PubMed     Abstract available
     
     
     
245. DESAI AN, Kim AY
     Management of Hepatitis A in 2020-2021.
     JAMA. 2020 Jul 6. pii: 2768154. doi: 10.1001/jama.2020.4017.
     PubMed    
     
     
     May 2020
246. DEL RIO C, Malani P
     Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response.
     JAMA. 2020 May 22. pii: 2766600. doi: 10.1001/jama.2020.9252.
     PubMed    
     
     
     
247. HALL MA, Studdert DM
     Privileges and Immunity Certification During the COVID-19 Pandemic.
     JAMA. 2020 May 6. pii: 2765835. doi: 10.1001/jama.2020.7712.
     PubMed    
     
     
     
248. PERSAD G, Emanuel EJ
     The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
     JAMA. 2020 May 6. pii: 2765836. doi: 10.1001/jama.2020.8102.
     PubMed    
     
     
     February 2020
249. WONG JEL, Leo YS, Tan CC
     COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action.
     JAMA. 2020 Feb 20. pii: 2761890. doi: 10.1001/jama.2020.2467.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: